He completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing ...

Ketamine is rarely lethal, but an overdose can cause unconsciousness and dangerously slowed breathing, according to the Drug ...

While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Tens of millions of people with depression aren't properly diagnosed. Stanford researchers show that brain imaging could revolutionize treatment. Researchers at Stanford recently described six ...

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that tran ...

Relief Mental Health, an award-winning outpatient provider of innovative mental health services, proudly announces the ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic sector.

Intravenous ketamine and intranasal esketamine may reduce emergency department visits for suicide in patients with treatment resistant depression.

Objective Ketamine and esketamine have both shown significant antidepressant effects in treatment-resistant depression (TRD) and conflicting evidence suggests that dissociation induced by these drugs ...